Don't let it get away!
Keep track of the stocks that matter to you.
Help yourself with the Fool's FREE and easy new watchlist service today.
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
So what: A broad market meltdown appears to be to blame for Star's suffering this time. For long-term investors, it's an opportunity to get in at … 28 times book value and 566 tomes sales. Ouch.
Now what: Bullish investors will rightly counter that Star's CigRX dietary supplements are no different from any in-development drug and that the potential payoff for reducing or eliminating cigarette cravings could be in the billions. In that sense, today's selloff could be a non-event. Do you agree? Disagree? Weigh in using the comments box below.
Interested in more info on Star Scientific?Add it to your watchlist.